Robert B. Bazemore, President & CEO at Epizyme, Inc. (EPZM), sold 12,138 shares at $11.41 ($138K) on 2021-01-25, disclosed to the SEC on 2021-01-27.
Open-market sale of $138k EPZM by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.41 | 6,069 | $69K | 50.0% |
| 2 | $11.41 | 6,069 | $69K | 50.0% |
| Total | $11.41 avg | 12,138 | $138K | 100% |
| Filing → |
| EPZM | SELL | 2021-02-05 | $44K | — | Filing → |
| EPZM | SELL | 2020-06-30 | $154K | — | Filing → |
| EPZM | SELL | 2020-06-22 | $220K | — | Filing → |